Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Oxford Biomedica Ltd.
Commercial Physical And Biological Research United Kingdom
Company Description
Oxford Biomedica Ltd. engages in the biopharmaceutical business. It develops gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. It collaborates and develops novel targeted therapies and therapeutic vaccines to treat multiple types of cancer. Oxford Biomedica offers products, including prosavin, retinostat, stargen, ushstat, encorstat, monudin, trovax, targeted antibody therapy, hi-8 MEL, metXia and endoAngio-GT. Its technologies include lentiVector, 5T4 tumour antigen, Hi-8 primeboost, gene-directed enzyme prodrug therapy and anti-angiogenesis. The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom.
Similar to: Advanced Cell Technology, Inc., Medivir AB, Exelixis, Inc.
Featured Company
Utilico Emerging Markets Ltd.
Epsom, SU, GB
Utilico Emerging Markets Ltd. (UEM) is the UK-based global emerging markets investment arm of Computershare, Ltd. (SY: CPU) in Australia.… Learn more →
You may also be interested in:
Exelixis, Inc.
South San Francisco, CA, US
Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →
Medivir AB
Stockholm, SE
Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →
Advanced Cell Technology,…
Marlborough, MA, US
Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →